{{Rsnum
|rsid=1155865
|Chromosome=4
|position=66868139
|Orientation=plus
|GMAF=0.2094
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 66.4 | 29.2 | 4.4
| HCB | 81.0 | 18.2 | 0.7
| JPT | 79.6 | 19.5 | 0.9
| YRI | 24.5 | 46.9 | 28.6
| ASW | 28.1 | 49.1 | 22.8
| CHB | 81.0 | 18.2 | 0.7
| CHD | 78.0 | 21.1 | 0.9
| GIH | 49.5 | 42.6 | 7.9
| LWK | 30.0 | 55.5 | 14.5
| MEX | 75.9 | 22.4 | 1.7
| MKK | 35.9 | 51.3 | 12.8
| TSI | 75.5 | 22.5 | 2.0
| HapMapRevision=28
}}

{{GWAS Summary
|SNP=rs1155865
|PubMedID=17903297
|Condition=Cognitive test performance
|Gene=Intergenic
|Risk Allele=
|pValue=2.00E-006
|OR=NA
|95CI=
|OA=1
}}

{{PMID|17903297|OA=1
}} non sig. gwas, top 25 GEE p-values, Boston Naming Test

{{PharmGKB
|RSID=rs1155865
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:17903297; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham Study (Initial Sample Size: 705 individuals (Framingham); Replication Sample Size: NR). This variant is associated with Cognitive test performance.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356440
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1155865
|overall_frequency_n=97
|overall_frequency_d=128
|overall_frequency=0.757812
|n_genomes=50
|n_genomes_annotated=0
|n_haplomes=86
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}